Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

ClinicalTrials.gov ID: NCT00685113

Public ClinicalTrials.gov record NCT00685113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter study to evaluate the efficacy and safety of 2 different doses of DR-3001. For eligible subjects the duration of the study will be approximately 20 weeks; this will consist of a 4-week screening period, a 12-week treatment period and a 4-week follow-up period. Subjects will have physical and laboratory exams, including blood draws at each scheduled visit. Subjects will be required to insert a vaginal ring (replacing it every 4 weeks) and to keep a daily record of their toilet voids (including time,type and volume) for 3 days at several specified time points.

Study identification

NCT ID
NCT00685113
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
1,104 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2008 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Jul 20, 2016

2008 – 2010

United States locations

U.S. sites
81
U.S. states
31
U.S. cities
71
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801 —
Duramed Investigational Site Mobile Alabama 36608 —
Duramed Investigational Site Montgomery Alabama 36116 —
Duramed Investigational Site Phoenix Arizona 85015 —
Duramed Investigational Site Tucson Arizona 85712 —
Duramed Investigational Site Tucson Arizona 85741 —
Duramed Investigational Site Little Rock Arkansas 72205 —
Duramed Investigational Site Encinitas California 92024 —
Duramed Investigational Site Los Angeles California 90036 —
Duramed Investigational Site San Diego California 92103 —
Duramed Investigational Site San Diego California 92108 —
Duramed Investigational Site San Diego California 92123 —
Duramed Investigational Site Colorado Springs Colorado 80909 —
Duramed Investigational Site Denver Colorado 80220 —
Duramed Investigational Site Danbury Connecticut 06810 —
Duramed Investigational Site Milford Connecticut 06460 —
Duramed Investigational Site New London Connecticut 06320 —
Duramed Investigational Site Aventura Florida 33180 —
Duramed Investigational Site Gainesville Florida 32607 —
Duramed Investigational Site Jacksonville Florida 32207 —
Duramed Investigational Site Miami Florida 33143 —
Duramed Investigational Site New Port Richey Florida 34655 —
Duramed Investigational Site Tampa Florida 33607 —
Duramed Investigational Site West Palm Beach Florida 33407 —
Duramed Investigational Site West Palm Beach Florida 33409 —
Duramed Investigational Site Atlanta Georgia 30308 —
Duramed Investigational Site Augusta Georgia 30901 —
Duramed Investigation Site Decatur Georgia 30034 —
Duramed Investigational Site Savannah Georgia 31406 —
Duramed Investigational Site Boise Idaho 83704 —
Duramed Investigational Site Boise Idaho 83712 —
Duramed Investigational Site Coeur d'Alene Idaho 83814 —
Duramed Investigational Site Meridian Idaho 83642 —
Duramed Investigational Site Fort Wayne Indiana 46825 —
Duramed Investigational Site Jeffersonville Indiana 47130 —
Duramed Investigational Site South Bend Indiana 46601 —
Duramed Investigational Site Newton Kansas 67114 —
Duramed Investigational Site Wichita Kansas 67207 —
Duramed Investigational Site Louisville Kentucky 40291 —
Duramed Investigational Site Lafayette Louisiana 70503 —
Duramed Investigational Site Marrero Louisiana 70072 —
Duramed Investigational Site Shreveport Louisiana 71106 —
Duramed Investigational Site Watertown Massachusetts 02472 —
Duramed Investigational Site Las Vegas Nevada 89109 —
Duramed Investigational Site Las Vegas Nevada 89128 —
Duramed Investigational Site North Las Vegas Nevada 89030 —
Duramed Investigational Site Lebanon New Hampshire 03756 —
Duramed Investigational Site Lawrenceville New Jersey 08648 —
Duramed Investigational Site Moorestown New Jersey 08057 —
Duramed Investigational Site New Brunswick New Jersey 08901 —
Duramed Investigational Site Albuquerque New Mexico 87102 —
Duramed Investigational Site Port Jefferson New York 11777 —
Duramed Investigational Site New Bern North Carolina 28562 —
Duramed Investigational Site Winston-Salem North Carolina 27103 —
Duramed Investigational Site Cleveland Ohio 44122 —
Duramed Investigational Site Mayfield Heights Ohio 44124 —
Duramed Investigational Site Bethany Oklahoma 73008 —
Duramed Investigational Site Oklahoma City Oklahoma 73112 —
Duramed Investigational Site Eugene Oregon 97401 —
Duramed Investigational Site Medford Oregon 97504 —
Duramed Investigational Site Philadelphia Pennsylvania 19104 —
Duramed Investigational Site Philadelphia Pennsylvania 19114 —
Duramed Investigational Site Pittsburgh Pennsylvania 15206 —
Duramed Investigational Site Pottstown Pennsylvania 19464 —
Duramed Investigational Site Charlestown South Carolina 29425 —
Duramed Investigational Site Columbia South Carolina 29201 —
Duramed Investigational Site Greensville South Carolina 29605 —
Duramed Investigational Site Hilton Head Island South Carolina 29926 —
Duramed Investigational Site Jackson Tennessee 38305 —
Duramed Investigational Site Dallas Texas 75234 —
Duramed Investigational Site Dallas Texas 75390 —
Duramed Investigational Site Dallas Texas 78229 —
Duramed Investigational Site Houston Texas 77024 —
Duramed Investigational Site San Antonio Texas 78209 —
Duramed Investigational Site San Antonio Texas 78229 —
Duramed Investigational Site Waco Texas 76712 —
Duramed Investigational Site Salt Lake City Utah 84107 —
Duramed Investigational Site Williston Vermont 05495 —
Duramed Investigational Site Norfolk Virginia 23507 —
Duramed Investigational Site Seattle Washington 98105 —
Duramed Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00685113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00685113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →